Moderna Plans to Produce 20 Million Doses of Its COVID-19 Vaccine Candidate in 2020The Motley Fool • 09/18/20
3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each OtherThe Motley Fool • 09/18/20
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis TherapyThe Motley Fool • 09/18/20
Moderna trial investigator worries about political pressure in vaccine approval processCNBC • 09/17/20
COVID-19 Vaccine Developer Moderna In The Spotlight With R&D Day, 2 CollaborationsBenzinga • 09/17/20
3 Reasons Why You Probably Won't Receive a Coronavirus Vaccine Shot by the End of 2020The Motley Fool • 09/17/20
Moderna Announces Progress Across Broad Portfolio and all Three Clinical Stage Therapeutic Areas at 2020 R&D DayBusiness Wire • 09/17/20
Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene EditingBusiness Wire • 09/16/20
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH)Business Wire • 09/16/20